Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · IEX Real-Time Price · USD
0.753
-0.003 (-0.42%)
At close: Dec 29, 2023, 4:00 PM
0.751
-0.002 (-0.23%)
After-hours: Dec 29, 2023, 5:47 PM EST
Adverum Biotechnologies Stock Forecast
Stock Price Forecast
According to 4 stock analysts, the average 12-month stock price forecast for ADVM stock stock is $3.50, which predicts an increase of 364.93%. The lowest target is $2.00 and the highest is $6.00. On average, analysts rate ADVM stock stock as a strong buy.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 2, 2023.
Analyst Ratings
The average analyst rating for ADVM stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 4 | 4 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Strong Buy Initiates $2 | Strong Buy | Initiates | $2 | +165.67% | Nov 2, 2023 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +697.02% | Sep 5, 2023 |
| Chardan Capital | Chardan Capital | Hold → Strong Buy Upgrades $2 → $4 | Hold → Strong Buy | Upgrades | $2 → $4 | +431.35% | Aug 11, 2023 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $2 | Strong Buy | Initiates | $2 | +165.67% | Mar 7, 2023 |
| Chardan Capital | Chardan Capital | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | +165.67% | Nov 11, 2022 |
Financial Forecast
Revenue This Year
3.74M
Revenue Next Year
n/a
from 3.74M
EPS This Year
-1.26
from -1.56
EPS Next Year
-0.91
from -1.26
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 4.2M | n/a | 63.0M | 63.0M | 81.1M | 48.3M |
| Avg | 3.7M | n/a | 15.3M | 15.3M | 39.3M | 22.4M |
| Low | 3.5M | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | 311.8% | 430.3% | 22.8% |
| Avg | - | - | - | - | 157.1% | -43.0% |
| Low | - | - | - | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -1.21 | -0.63 | -0.59 | -0.61 | -0.49 | -0.45 |
| Avg | -1.26 | -0.91 | -0.90 | -0.80 | -0.74 | -0.66 |
| Low | -1.30 | -1.18 | -1.14 | -1.11 | -1.03 | -0.84 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | - |
| Avg | - | - | - | - | - | - |
| Low | - | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.